Biotech Values

[mcbio]

Re: CYPB Board rejecting $6/share Ramius offer

Unfortunately, Ramius and Royalty Pharma learned Monday night that the Board had rejected its offer and that the Company is pursuing an alternative transaction with a third party. Ramius and Royalty Pharma believe that the Company is now considering a less certain, alternative transaction with this third party.

Count me as happy to hear that apparently another party is involved in discussions with CYPB. I would assume that the Board would reject the Ramius offer because it believes that a better offer may await with this other party. Any guess as to who the third party could be? FRX?